House bill reauthorizes ALS therapy access program
/ 1 min read
Table of Contents
This bill, titled the Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026, would extend existing programs that help people with Amyotrophic Lateral Sclerosis (ALS) access specific medical treatments.
Why it matters: This is a procedural step to keep specific medical access programs running; without reauthorization, these processes could expire or change.
Who it affects
- People living with ALS who require specific therapies
This information comes from Congress.gov regarding a House bill; please check the official text before relying on it for medical or legal decisions.
Agency: House
Source: Congress.gov — read the official document